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The restrictive properties of tripartite motif-containing 5 alpha (TRIM5) from small ruminant species have not been explored.
Here, we identify highly similar TRIM5 sequences in sheep and goats. Cells transduced with ovine TRIM5 effectively re-
stricted the lentivirus visna/maedi virus DNA synthesis. Proteasome inhibition in cells transduced with ovine TRIM5 restored
restricted viral DNA synthesis, suggesting a conserved mechanism of restriction. Identification of TRIM5 active molecular spe-
cies may open new prophylactic strategies against lentiviral infections.
Small ruminant lentiviruses (SRLV), including visna/maedivirus (VMV) and caprine encephalitis virus (CAEV), are
widespread in sheep and goats, causing a slow progressive dis-
ease. Since neither treatment nor efficient vaccines are avail-
able, infection is commonly controlled by early diagnosis and
culling (23). Recently, the study of host cell restriction factors
interfering with the retroviral life cycle, such as the tripartite
motif-containing 5 (TRIM5) protein, has gained interest (10,
37). TRIM5 family members bear a RING–B-box– coiled-coil
structure consisting of an N-terminal RING domain (with E3
ubiquitin ligase activity), a B-box domain, and a coiled-coil
domain (19). The TRIM5 isoform, which is active against
retroviruses, contains a C-terminal PRYSPRY domain that
binds retroviral capsid CA (12, 20, 35). This interaction, in-
volving amino acid 332 of TRIM5 in humans (15) and 334 in
monkeys, may explain the high relative rates of nonsynony-
mous changes of the primate TRIM5 gene (13). TRIM5 has
been described in primates and several mammals (3, 6, 30, 33,
41) but not in sheep or goats, both of which are infected by
SRLV, their own lentivirus. This study aimed to identify and
characterize the ovine and caprine TRIM5 proteins and ex-
plore the possible restrictive role of ovine TRIM5 on VMV
infection.
First, we cloned and sequenced ovine and caprine TRIM5
cDNA sequences. For this, total RNA from ovine skin fibro-
blasts (SF), bronchoalveolar lavage (BAL) fluid, or lung tissue
obtained from domestic sheep of the Assaf (n  3), Churra
(n 2), and Rasa Aragonesa (n 4) breeds was purified using
TRIzol (Invitrogen) passed through RNeasy minikit columns
(Qiagen), before being reverse transcribed with SuperScript II
(Invitrogen) using an oligo(dT) primer according to the man-
ufacturer’s instructions. To clone the caprine counterpart,
cDNA from peripheral blood mononuclear cells (PBMC) from
goats of the Roccaverano (n  1) and Murciano-Granadina
(n  2) breeds was used. These cDNAs were employed as the
PCR template using Phusion high-fidelity DNA polymerase
(Finnzymes) with the forward primer TrimEXNFw (5=-TGCA
CCTCGAGATGGCTTCAGGAATCCTG-3=, XhoI site under-
lined) and the reverse primer PJ2 (5=-GATCCGGGCCCTCAAC
AGCTTGGTGAGC-3=, ApaI site underlined) following standard
thermal profiles. Amplified products were cloned into the TOPO
Blunt vector (Invitrogen) as a shuttle/sequencing vector, yielding
a total of 12 ovine and 5 caprine independent sequences. Four
ovine sequenceswere obtained at least twice andwere alignedwith
previously described TRIM5 sequences (ClustalX and PHYLIP:
Phylogeny Inference Package version 3.5c), revealing a conserved
structure across species. Analysis of six clones from SF of one Rasa
Aragonesa sheep revealed the presence of only two TRIM5
amino acid sequences (named Ov1 and Ov2), suggesting that
these sequences are encoded by a single heterozygous gene. The
sequences differed only at a single residue (39) of the PRYSPRY-
domain V1 region. Greater levels of amino acid diversity were
found in additional sheep and goat sequences (Fig. 1). To examine
sequence diversity, phylogenetic trees were produced by the
neighbor-joining method with Kimura’s correction using 1,000
bootstrap confidence limits. Results with over 950 bootstrapswere
considered highly likely. As expected, ovine and caprine sequences
were closely related, followed by bovine sequences (Table 1),
forming a nonprimate TRIM5 cluster (Fig. 2). Comparison of
these sequences revealed greater variation between caprine and
ovine TRIM5 proteins than between ovine sequences (Table 1;
Fig. 1A), with the PRYSPRY being themost variable domain. Such
variation was higher than expected given that sheep and goats
diverged 6 million years ago (16), whereas humans and chimpan-
zees, which encode more highly related TRIM5 sequences, di-
verged 7 million years ago (5). The close relatedness between
sheep and goats is consistent with the ability of sheep (VMV) and
goat (CAEV) lentiviruses to infect both ruminant species (8, 32).
The high variability of both PRYSPRY (6, 34; this work) andCAof
SRLV (7, 26)may account for the evolution of both virus and host,
involving TRIM5 and CA interactions, as described for primate
lentiviruses (11, 28, 34, 38). Natural selection in ovine and caprine
sequences was determined by estimating  (ratio of the rate of
nonsynonymous substitutions, dN, to synonymous substitutions,
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Ov1 MASGILMNIQEEVTCPICLELLTEPLSLDCGHTFCQACIAANNEESTVGQEGHKSCPVCRVSFEPGNLRPNRHVANIVQR 80
Ov2 ................................................................................ 80
Ov3 .......................................T........................................ 80
Ov4 .......................................T........................................ 80
Caprine .........................R.............T......I.....K........................... 80
Bovine .......................................TG..K..II....KR..................N....... 80
Ov1 LREVKVRPEVEQERNLCAHHGEKLQLFCEQDGKVICWLCERSQEHRGHNTFLMEEIAPQYQKMLQSCLQRLNGKKQEAEE 160
Ov2 ................................................................................ 160
Ov3 ................................................................................ 160
Ov4 ................................................................................ 160
Caprine ......S........................E........................................R....... 160
Bovine ......S...................................................E...K........K........ 160
Ov1 LEIKVREEMSTWKTQIENEMQSVQGEFTKLRQILDSEEAKELRKLKDELGIILKKLAESENDLVQEKLLVSSHISDVERH 240
Ov2 ................................................................................ 240
Ov3 ................................................................................ 240
Ov4 ................................................................................ 240
Caprine ................QT.I..............................V...V........D......NNL....... 240
Bovine .............I.....I.N...K..Q.........M...........V...E................NL....... 240
Ov1 LQGSTMELLQDVNVILKRSKTVALKEPKTFPKEQRRVFRAPDLREILRVFTELTNKQRYWVQVTLNSPKNAN-VISPHQR 319
Ov2 ........................................................................-....... 319
Ov3 ......................................................DM................-....R.. 319
Ov4 ........................................................................-....... 319
Caprine ...................E...........E..................N...DM.H..............-....D.. 319
Bovine ...........A...I...E.L...K..S.....................N...DV............RS..V....D.. 320
Ov1 QVRYASRYQHCNAYSKDNYEDFGVLGSPVITSGRHYWEVDVSEKRAWILGICDENCKNIMKLPLELGNYGNGNCQNVYSL 399
Ov2 ...................K............................................................ 399
Ov3 ......S......................................................................... 399
Ov4 ................................................................................ 399
Caprine ......S..CY...............................K.............E.....T.Q..K...R........ 399
Bovine ......ND.RS.V.LI..C.V.S...................K.......V.G..---..IE.PIF..F....YS..F.V 397
Ov1 YKPKNGNCGNGKNVYSRYQPTNGYWVIGLKQDSVYNAFLD----LEILALSLGVSPHRVGVFLDYEACSVLFLNVTNRGF 475
Ov2 ........................................----.................................... 475
Ov3 ........................................----....T............................H.. 475
Ov4 ........................................----....T............................H.. 475
Caprine H...................K...................----IG..T..................RT........Y.. 475
Bovine .Q...R....SQ........K.........H....K..ESSFSGP...T...S.....I.I......RT........H.. 477
Ov1 PIYKFSSCSFPQKIVPYFNPMNCDAPMTLCSPSCZ 510
Ov2 ................................... 510
Ov3 ................................... 510
Ov4 ................................... 510
Caprine ......L......V..............V...... 510
Bovine ............N...................... 512
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B
FIG 1 TRIM5 amino acid sequences from ruminants. (A) Alignment of TRIM5 amino acid sequences from ovine (Ov1 to Ov4), caprine, and bovine species.
Ov1 and Ov2 were amplified from skin fibroblasts of one seronegative Rasa Aragonesa breed sheep. Ov3 and Ov4 were amplified from bronchoalveolar lavage
fluid cDNA from a seropositive Rasa Aragonesa sheep. RING, B-box-2, coiled-coil, and PRYSPRY domains are shown, and the variable segments (V1, V2, and
V3) of this domain are outlined. Amino acid differences between ovine sequences (Ov1 to Ov4), including those corresponding to V1 residue 339 among others,
are highlighted in gray. Accession numbers (GenBank) are as follows: Ov1 to Ov4, JN835300 to JN835303; caprine, JQ582845; bovine, DQ380509. (B) Structure
of the ovine TRIM5: full-length isoform (top) and an alternatively spliced form (bottom).
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dS), using three methods: single-likelihood ancestor counting
(SLAC), fixed effects likelihood (FEL), and random effects likeli-
hood (REL) implemented in theDatamonkeywebserver (21). The
existence of strong positive selection observed when comparing
other species (6, 17, 29, 34) was not observed in sheep-versus-goat
comparisons (P  0.064), consistent with viral transmission be-
tween these species.
Additional RNA species (6 from a total of 3 sheep) were
identified that had a stop codon at residue 347 compared to the
full ovine protein TRIM5 (OvT5), resulting in a reduced
number of exons and elongated noncoding sequences at the 3=
end, a structure similar to that of human TRIM5 (2) (Fig. 1B).
No splicing donor/acceptor consensus sequences were found
in the shortened TRIM5 sequences under study, suggesting
that truncated proteins are indeed splice variants of TRIM5
and that splicing of these forms is conserved between primates
and ruminants. Numerous isoforms that are shorter than the
antiviral TRIM5 exist in humans (2) and macaques (4). Some
of these lack the PRYSPRY domain and are therefore unrestric-
tive. Like human TRIM5 (36), the short ovine isoform is likely
to act as a dominant negative through lack of a viral binding
PRYSPRY domain (2).
To characterize restriction by OvT5, sequences Ov1, Ov2
(both from SF of a seronegative Rasa Aragonesa sheep from a
seropositive flock), and Ov4 (obtained from BAL fluid cells of a
Rasa Aragonesa seropositive sheep affected with pneumonia)
were cloned into the gammaretroviral expression vector
pCNCR-HA, using XhoI/ApaI restriction sites. The vector con-
tains the LTR of Moloney murine leukemia virus (MLV), driv-
ing expression of an N-terminal hemagglutinin (HA)-tagged
OvT5 protein and the gene for the red fluorescent protein
(RFP). The resulting vector (pCTCR-HAOvT5) was packaged
into vesicular stomatitis virus G envelope protein (VSV-G)-
pseudotyped MLV cores by cotransfection of 293T cells as de-
scribed previously (3). Culture supernatants containing MLV
virions encoding OvT5 were used to transduce the Mus dunni
tail fibroblast (MDTF) cell line, and HA-tagged OvT5 stably
expressing cells were obtained. Cells transduced with empty
pCNCR-HA were used as controls. Single cell clones were iso-
lated by limiting dilution, identified by red fluorescence mi-
croscopy, expanded, and checked for expression of TRIM5
proteins by Western blotting (WB) using anti-HA antibodies
and quantitative reverse transcriptase PCR (RT-PCR) with for-
ward (qPCR3T5Fw: 5=-TTCCTAGACTATGAGGCTTGCTCTG
T-3=) and reverse (qPCR3T5Rv: 5=-TTCTGAGGAAAGGAACAT
GAAGAGA-3=) primers, designed within the PRYSPRY region.
-ActinRT-PCR allowed relative quantification using the primers
described (24).
Transduced MDTF cells expressed OvT5-HA according to
the results of WB (Fig. 3B) and RT-PCR (not shown). These
OvT5-expressing clones were subjected to infection by VMV
strain Ev1 (27) to study restriction. The dose was determined
by titrating Ev1 by inoculation of 10-fold serial dilutions onto
ovine SF and visualization of the cytopathic effect by micros-
copy after 7 days. Titers, calculated by the Reed-Muench
method (22), were expressed as 50% tissue culture infectious
doses (TCID50) per ml. Cells were infected at an apparent mul-
tiplicity of infection (MOI) of 0.2, and 16 h later MDTF total
DNA was purified using a QIAamp DNA minikit (Qiagen).
TaqMan quantitative PCR (qPCR) was used to measure viral
DNA synthesis using a plasmid standard curve as described
previously (9). Strain Ev1 entered and was reverse transcribed
in the MDTF cells. Viral DNA was detected by qPCR (mean
copy number/100 ng DNA when infecting at 0.2 TCID50/cell,
9.9  102), and viral transcripts were produced according to
RT-PCR (not shown). Thus, heterologous MDTF cells were
suitable for assessing OvT5-mediated restriction, even though
infection was not productive since supernatants had no RT
activity up to day 20 postinoculation (not shown). Measure-
ment of viral DNA synthesis indicated that MDTFs transduced
with OvT5 were less permissive to reverse transcription than
control MDTFs (P  0.05). We conclude that OvT5 was able
to significantly restrict VMV infectivity. TRIM5Ov1 and Ov2
were able to restrict Ev1 whereas TRIM5Ov4 was not, despite
strong expression detected by immunoblotting (Fig. 3A and B).
In the TRIM5 protein of humans and simians, a single amino
acid substitution at position 332 or 334 abrogates TRIM5-
mediated restriction of particular viruses due to its essential
role in viral recognition (13). Specifically, any non-positively
charged amino acid at that position, which belongs to a “patch”
of positively selected positions, improves CA binding (15).
Surprisingly, Ov1 and Ov2 had either a positively charged
amino acid (K) or a negative residue (E) at this position
(Fig. 1A), but both showed a similar restriction of Ev1 inMDTF
cells. Due to the poor alignment of this highly variable region,
it is difficult to be sure that this amino acid is analogous to
primate TRIM5 position 339, but it is certainly very close and
putatively present on the surface of the protein in the highly
variable loop that is most important for determining TRIM5
specificity. Recent studies highlight the importance of domains
other than PRYSPRY (18). Significantly, Ov4 had differences in
the RING and PRYSPRY domains compared with Ov1 and Ov2
TABLE 1 Sequence identity matrixa
Sequence type
% Similarity with sequence type
Ov2 Ov3 Ov4 Caprine Bovine
T5 PRYSPRY T5 PRYSPRY T5 PRYSPRY T5 PRYSPRY T5 PRYSPRY
Ov1 99 99 98 98 99 99 91 89 84 76
Ov2 98 97 99 98 91 89 83 75
Ov3 99 99 92 90 84 77
Ov4 92 90 84 77
Caprine 84 75
a Sequence identity matrix for the complete coding sequence (CDS) of the TRIM5 protein (T5) and its PRYSPRY domain, using the ovine (Ov1, Ov2, Ov3, and Ov4) and caprine
amino acid sequences obtained and a bovine sequence (DQ380509) available at GenBank.
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andmay have lost restrictive activity against VMV. Indeed, Ov4
was obtained from an infected sheep, consistent with a permis-
sive TRIM5 genotype.
In addition, we tested the restrictive role of OvT5 against VSV-
G-pseudotyped HIV-2 viral vectors encoding green fluorescent
protein (GFP), prepared by Fugene-6 transfection of 293T cells as
described previously (10). We infected OvT5-MDTF cells and
quantified infection at 48 h by measuring GFP expression using
flow cytometry (BD FACScalibur).MDTFs showed decreased lev-
els of HIV-2 infection when expressing Ov2 (Fig. 3A), strongly
suggesting a role for OvT5 in protecting sheep from HIV-2 infec-
tion.
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FIG 2 Phylogenetic tree of TRIM nucleotide sequences of different species. The tree shows that all the sheep and goat TRIM5 sequences described in this work
are TRIM5 orthologues. GenBank accession numbers shown are for sequences from the following sources: JN835300 and JN835301, Rasa Aragonesa skin
fibroblasts; JN835302 and JN835303, Rasa Aragonesa bronchoalveolar lavage fluid; JN835304, Rasa Aragonesa lung tissue; JN835305, lung tissue of two Rasa
Aragonesa and two Assaf sheep; JN835306, lung tissue of two Assaf and one Churra sheep; JN835307, Assaf lung tissue; JN835308, Rasa Aragonesa lung tissue;
JN835309, Rasa Aragonesa lung tissue; JN835310, Churra lung tissue; JN835311, lung tissue of one Assaf and one Churra sheep; JQ582845, peripheral blood
mononuclear cells of a Roccaverano goat; JQ582846 to JQ582848, peripheral blood mononuclear cells of a Murciano-Granadina goat; JQ582849, peripheral
blood mononuclear cells of a Murciano-Granadina goat.
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Since the proteasome has been shown to be involved in
TRIM5 restriction in other species (1, 25, 40), we inhibited the
proteasome and examined OvT5-mediated restriction of VMV.
MDTF cells expressing TRIM5Ov2 or empty vector were treated
with prewarmed (37°C) proteasome inhibitor MG132 (Sigma-
Aldrich) at a final concentration of 25M for 1 h before infection
with Ev1 at an MOI of 0.2. After 16 h of infection, viral DNA was
quantified in duplicate by qPCR as described above, and the ex-
periment was repeated three times. The results indicated that viral
DNAwas significantly increased (P 0.01) in proteasome-inhib-
ited MDTF cells expressing a restrictive OvT5 compared to un-
treated cells. Either treated or untreated cells transduced with an
empty vector showed no viral restriction, having similar levels of
viral DNA (Fig. 4). The involvement of the proteasome in OvT5
restriction is in line with findings on other lentiviruses (1, 40).
TRIM5 has been characterized mostly in the context of
restricting heterologous viruses, but as shown here homolo-
gous virus restriction may also take place upon overexpression
of TRIM5 (14, 42). This suggests that differences in TRIM5
expression levels as well as intrinsic antiviral specificity may
account for differences in permissiveness to infection between
individuals (31, 42). Importantly, our study suggests func-
tional differences between polymorphic ovine TRIM5 vari-
ants to restrict both heterologous (HIV-2) and homologous
(VMV) viruses. A better understanding of these differences
could eventually be used to design SRLV control strategies such
as identification and selective breeding of animals that are less
permissive to infection, thus avoiding culling and helping to
reduce viral load and therefore disease development.
Nucleotide sequence accession numbers. The nucleotide se-
quences obtained in this work were deposited in GenBank under
accession numbers JN835300 to JN835311 (ovine) and JQ582845
to JQ582849 (caprine).
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FIG 4 Effect of proteasome inhibition on VMV DNA levels in ovine OvT5-
expressing cells. MDTF cells expressing restrictive OvT5 Ov2 or transduced
with an empty CNCR-HA vector were treated for 1 h with proteasome inhib-
itorMG132 (untreated cells were used as a control) before infectionwithVMV
strain Ev1, and viral DNA was measured 16 h after infection by qPCR using
Ev1-specific primers/probe. Data represent viral DNA copy numbers (mean	
standard error) per 100 ng of total DNA. Three independent experiments were
performed.
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FIG 3 Ovine TRIM5 (OvT5)-mediated restriction. (A) MDTF cells expressing OvT5 were infected with GFP-expressing HIV-2 VSV-G pseudotyped
lentiviral vector or VMV strain Ev1. Data represent viral DNA copy numbers (mean values	 standard error) per 100 ng of total DNA obtained by qPCR using
Ev1-specific primers/probe (9) or infectious units per ml in the case of HIV-2. Cells transduced with pCNCR-HA were used as negative controls. Three
independent experiments were performed. (B) Western blot illustrating the expression of different HA-OvT5 sequences in MDTF cells (transduced pCTCR-
HA-OvT5 or empty vector CNCR), using anti-HA-tag antibodies.
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